Serina Therapeutics Inc. (SER)
NYSE · Healthcare
Serina Therapeutics Inc. EBITDA 2017–2025
Serina Therapeutics Inc. annual/quarterly ebitda history and growth rate from 2018 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Serina Therapeutics Inc. ebitda for the quarter ending March 31, 2025 was -5.9 M, a 155.14% increase year-over-year.
- Serina Therapeutics Inc. ebitda for the twelve months ending March 31, 2025 was -11.1 M, a 7.94% increase year-over-year.
- Serina Therapeutics Inc. annual ebitda for 2025 was -23.9 M, a 41.15% increase from 2024.
- Serina Therapeutics Inc. annual ebitda for 2024 was -16.9 M, a 457.68% increase from 2023.
- Serina Therapeutics Inc. annual ebitda for 2023 was -3.0 M, a 67.67% decrease from 2020.
- Serina Therapeutics Inc. annual ebitda for 2020 was -9.4 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Serina Therapeutics Inc. EBITDA — FAQ
Serina Therapeutics Inc. (SER) ebitda over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SER's ebitda history?
The chart and table above show Serina Therapeutics Inc.'s ebitda by year and by quarter, including the growth rate.